No. 45

ANS news

‎Decisions of the 631st Board of Directors Meeting

Check the topics discussed at the meeting held on Friday, Dec 5

00:6:56 – ITEM 1 – Approval of the draft minutes of the 630th Ordinary Meeting of the Board of Directors and the 14th Extraordinary Meeting of the Board of Directors of 2025, held on Oct 31 and Nov 24, respectively.

DECISION: ITEM APPROVED.

00:7:26 – ITEM 2 DIPRO – Consideration of the proposal to update the health regions used in supplementary health regulation, without change in substance and with a change in the type of normative act provided for in §2 of article 1 of Normative Resolution (RN) 566/2022, in compliance with the legal mandate established by art. 9, item I, of Decree 12,002/2024.

DECISION: ITEM CONSIDERED.

00:20:38 – ITEM 3 DIPRO – Consideration of the proposed normative act on the transfer of the portfolio of beneficiaries of private health care plan operators.

DECISION: ITEM CONSIDERED.

00:52:38 – ITEM 4 PRESI – Consideration and approval of the normative proposal to issue a normative act amending the internal regulations of the Federal Attorney’s Office at ANS.

DECISION: ITEM CONSIDERED AND APPROVED.

01:00:35 – ITEM 5 DIPRO – Decision on the Regulatory Outcome Assessment of RN 441/2018. Review of the Parameters that make up the methodology for calculating the annual price adjustment of regulated individual and family plans.

DECISION: ITEM DECIDED.

01:16:02 – ITEMS 6 and 7 DIFIS – Approval of the proposals to enter into a Conduct Adjustment Commitment Agreement between ANS and the Instituto de Cirurgia Reconstrutora and between ANS and the Fundação Pró-Tocantins, both aimed at settling an infraction involving article 18 of RN 489/2022.

DECISION: ITEMS APPROVED.

01:19:20 – ITEMS 8 and 9 DIFIS – Approval of the Technical Cooperation Agreements between ANS and the Tribunal de Justiça do Estado do Mato Grosso do Sul and between ANS and the Ministério Público do Estado do Rio Grande Do Sul, both under the Programa Parceiros da Cidadania.

DECISION: ITEMS APPROVED.

01:24:56 – ITEM 10 OFF-AGENDA DIDES – Decision on the administrative appeal filed by the Grupo Hapvida. Extraordinary settlement by adhesion.

DECISION: ITEM DECIDED.

01:38:38 – ITEM 11 OFF-AGENDA DIPRO – Decision on the proposal to update the List of Health Procedures and Events (Rol) – Preliminary Recommendation Technical Note (NTRP) concerning Technical Analysis Units (UATs) 178 – Surgical exclusion of the left atrial appendage (LAA), by means of a surgical clip, concomitant with open cardiac surgery, for patients with atrial fibrillation or at high risk of stroke; 179 – Cabozantinib levomalate for the treatment of patients with well-differentiated, unresectable, locally advanced or metastatic neuroendocrine tumors, previously treated with two or more therapies; and 182 – Enzalutamide in combination with androgen deprivation therapy for the treatment of non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence.

DECISION: ITEM DECIDED.

01:59:20 – ITEM 12 OFF-AGENDA DIPRO – Decision on the proposal to update the Rol – Final Recommendation Technical Note (NTRF) concerning UAT 167 – Guselkumab for the treatment of moderate to severe active ulcerative colitis or ulcerative proctocolitis in adult patients after failure, refractoriness, relapse or intolerance to anti-TNF therapy.

DECISION: ITEM DECIDED.

02:07:47 – ITEM 13 OFF-AGENDA DIPRO – Decision on the proposal to update the Rol – Health technologies positively recommended by the National Commission for the Incorporation of Technologies (Conitec) in the Unified Health System. Conitec Recommendation Report 1030, Aug 2025 “Robot-assisted radical prostatectomy procedure” for the treatment of patients with localized or locally advanced prostate cancer.

DECISION: ITEM DECIDED.

02:19:06 – ITEM 14 OFF-AGENDA DIPRO – Decision on the proposed Normative Resolution creating the Internal Rules of the Commission for the Update of the List of Procedures and Events in Supplementary Health (Cosaúde).

ANS includes first robotic surgery in the mandatory coverage of health plans

Procedure used in the treatment of prostate cancer will be available in April 2026 and reinforces progress in oncology care

Folha de S.Paulo publishes article by Wadih Damous

ANS Chief Executive Officer addresses the challenges of supplementary health and reinforces the importance of transparency and balanced rules for the sector

Link to the article: https://monitoring.knewin.com/front/noticia/?k=TVRFek1qZzVNVFUwSmpFMU9EYz0=&id=113289154

Public Consultation 164: ANS receives input for the update of the Rol

The National Supplementary Health Agency (ANS) opens, this Thursday, Dec 4, Public Consultation 164, with the aim of obtaining input on the proposals to update the List of Health Procedures and Events (Rol) for the following technologies:

Anti-beta 2 glycoprotein 1 test (IgG and IgM), an exam for the diagnosis of thrombophilia in pregnant women, a condition that can lead to obstetric complications, such as recurrent miscarriage and early preeclampsia; and

Quantitative polymerase chain reaction (RT-PCR) test, an exam for the diagnosis of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).

Interested parties may submit their input until Dec 23 on the ANS website itself, where the documents related to the proposals are also available during the consultation period.

ANS takes part in dialogue on modernizing the Health Plans Law

The Chief Executive Officer of the National Supplementary Health Agency (ANS), Wadih Damous, took part in a meeting on Dec 3 with federal deputy Domingos Neto, rapporteur of the bill to revise the Health Plans Law, and the Minister of Health, Alexandre Padilha. The meeting aimed to discuss the progress of the report and the needs to ensure modern and balanced legislation.

ANS holds webinar to release the economic and financial data for the 3rd quarter of 2025

The event will take place on Dec 11, with live streaming on YouTube, starting at 10 a.m.

ANS holds 120th meeting of the Supplementary Health Chamber

The meeting takes place on Dec 9, at 2:30 p.m., with streaming on YouTube